27 Stocks Moving in Wednesday's Pre-Market Session

Gainers

• Rail Vision Ltd. RVSN shares rose 38.5% to $1.87 in pre-market trading after gaining around 5% on Tuesday.
• Brickell Biotech, Inc. BBI rose 29% to $0.2999 in pre-market trading after the company announced the sale of sofpironium bromide to Botanix Pharmaceuticals for $9 million in upfront and potential near-term regulatory milestone payments. The company is also eligible to receive additional success-based regulatory and sales milestone payments of up to $168 million.
• Aclarion, Inc. ACON rose 28.5% to $2.21 in pre-market trading after declining over 5% on Tuesday. The company had its IPO on April 22.
• Livent Corporation LTHM rose 23.1% to $26.98 in pre-market trading after the company reported better-than-expected Q1 results and raised FY22 guidance.
• Sharps Technology, Inc. STSS rose 20.3% to $1.54 in pre-market trading after climbing around 6% on Tuesday.
• United States Antimony Corporation UAMY rose 16.5% to $0.48 in pre-market trading.
• CASI Pharmaceuticals, Inc. CASI rose 15% to $0.49 in pre-market trading.
• Senmiao Technology Limited AIHS rose 12.3% to $1.27 in pre-market trading.
• Amesite Inc. AMST shares rose 10.7% to $0.7096 in pre-market trading after declining over 6% on Tuesday.
• Alaunos Therapeutics, Inc. TCRT rose 9.9% to $0.61 in pre-market trading after jumping around 13% on Tuesday.
• Expion360 Inc. XPON rose 9.7% to $3.96 in pre-market trading. Expion360 secured $300,000 line of credit from GM Financial to support expansion of national sales and distribution channels.
• CNS Pharmaceuticals, Inc. CNSP rose 8.6% to $0.38 in pre-market trading.
• The Scotts Miracle-Gro Company SMG rose 7.6% to $114.00 in pre-market trading. Scotts Miracle-Gro announced record second-quarter sales in its U.S. consumer segment driven by continued support from its major retail partners.
• Starbucks Corporation SBUX rose 6.4% to $79.10 in pre-market trading as the company reported second-quarter revenue of $7.64 billion, which was up 15% year-over-year. The quarterly revenue was a second-quarter record for the company and came in ahead of a consensus estimate of $7.6 billion.
• Advanced Micro Devices, Inc. AMD shares rose 6% to $96.60 in pre-market trading after the company reported better-than-expected Q1 adjusted EPS and sales results and raised FY22 sales guidance.

Don’t forget to check out our premarket coverage here .

Losers

• Lyft, Inc LYFT shares fell 27.2% to $22.40 in pre-market trading. Lyft reported a narrower loss for its first quarter, while sales topped estimates. However, the company issued a weak outlook for the second quarter.
• Herbalife Nutrition Ltd. HLF shares fell 15.6% to $23.25 in pre-market trading after the company reported a decline in Q1 EPS results.
• Akamai Technologies, Inc. AKAM fell 13.9% to $98.02 in pre-market trading after the company reported worse-than-expected Q1 results.
• Blue Water Vaccines, Inc. BWV fell 13.5% to $5.58 in pre-market trading. Blue Water Vaccines S-1 showed registration for 2.4 million share common stock offering via selling shareholders.
• IonQ, Inc. IONQ shares fell 13.5% to $6.18 in pre-market trading. IonQ shares dropped 9% on Tuesday following a short report by Scorpion Capital.
• XORTX Therapeutics Inc. XRTX fell 10.9% to $1.63 in pre-market trading. XORTX Therapeutics shares jumped 59% on Tuesday after the company announced that dosing of human subjects has been initiated in the XRX-OXY-101 bridging pharmacokinetics study.
• Revolve Group, Inc. RVLV fell 9.9% to $39.20 in pre-market trading after the company reported Q1 earnings results.
• Swvl Holdings Corp. SWVL fell 8.5% to $6.62 in pre-market trading after dipping 17% on Tuesday.
• Sonoma Pharmaceuticals, Inc. SNOA shares fell 8.3% to $3.21 in pre-market trading. Sonoma Pharmaceuticals shares jumped around 32% on Tuesday after the company and its partner MicroSafe Group DMCC received EPA approval for Nanocyn as a hospital-grade disinfectant.
• Redbox Entertainment Inc. RDBX fell 7.6% to $6.12 in pre-market trading after dipping 22% on Tuesday.
• Ouster, Inc. OUST fell 6.3% to $3.25 in pre-market trading after the company reported worse-than-expected Q1 results.
• Match Group, Inc. MTCH fell 6.3% to $74.05 in pre-market trading after the company reported Q1 earnings results and issued Q2 sales guidance below analyst estimates.